Where it is registered
Each register with its number of medicines and a few of them.
United States
FDA · 9 medicines
- Sodium Phosphates1.34GM/5ML; 1.38GM/5ML (268MG/ML, 13.4GM/50ML; 13.8GM/50ML (268MG/ML, 4.02GM/15ML; 4.14GM/15ML (268MG/ML · solution · Fresenius Kabi USA
- Sodium Phosphates in Plastic Container4.02GM/15ML; 4.14GM/15ML (268MG/ML · solution · Hospira
- Monobasic Sodium Phosphate and Dibasic Sodium Phosphate0.398GM; 1.102GM · tablet · Novel Labs INC
- Osmoprep0.398GM; 1.102GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet · Salix Pharms
All medicines with Monohydrate
Every register, a page at a time. Strengths and packs are on each medicine’s page.
31 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Bosutinib Monohydrate | United States | 100MG BASE, 500MG BASE | tablet | Marketed | Alembic |
| MB CapsCombination | United States | Status unknown | |||
| Sodium PhosphatesCombination | United States | Status unknown | |||
| K Phos NeutralCombination | United States | Status unknown | |||
| UrelleCombination | United States | Status unknown | |||
| Nitrofurantoin (Monohydrate/Macrocrystals)Combination | United States | 75MG; 25MG | capsule | Marketed | Alvogen |
| Monobasic Sodium Phosphate and Dibasic Sodium PhosphateCombination | United States | 0.398GM; 1.102GM | tablet | Marketed | Novel Labs INC |
| Sodium PhosphatesCombination | United States | 1.34GM/5ML; 1.38GM/5ML (268MG/ML, 13.4GM/50ML; 13.8GM/50ML (268MG/ML, 4.02GM/15ML; 4.14GM/15ML (268MG/ML | solution | Marketed | Fresenius Kabi USA |
| Dextrose Monohydrate | United States | Status unknown | |||
| Sodium Phosphates in Plastic ContainerCombination | United States | 4.02GM/15ML; 4.14GM/15ML (268MG/ML | solution | Marketed | Hospira |
| Bosulif | United States | 100MG BASE, 50MG BASE | capsule | Marketed | PF Prism CV |
| Bosulif | United States | 100MG BASE, 400MG BASE, 500MG BASE | tablet | Marketed | PF Prism CV |
| OsmoprepCombination | United States | 0.398GM; 1.102GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Salix Pharms |
| VisicolCombination | United States | 0.398GM; 1.102GM | tablet | Not marketed | Salix Pharms |
| Mezlin | United States | 1GM BASE/VIAL, 20GM BASE/VIAL, 2GM BASE/VIAL … | injectable | Not marketed | Bayer Pharms |
| TricitratesCombination | United States | Status unknown | |||
| Beconase Aq | United States | 0.042MG DIPROP/SPRAY | spray, metered | Not marketed | Glaxosmithkline |
| Propulsid | United States | 1MG BASE/ML | suspension | Not marketed | Janssen Pharms |
| Propulsid | United States | 10MG BASE, 20MG BASE | tablet | Not marketed | Janssen Pharms |
| Propulsid Quicksolv | United States | 20MG BASE | tablet, orally disintegrating | Not marketed | Janssen Pharma |
| Vancenase Aq | United States | 0.042MG DIPROP/SPRAY, 0.084MG DIPROP/SPRAY | spray, metered | Not marketed | Schering |
| Egg Allergen MixCombination | United States | Status unknown | |||
| AllermilkCombination | United States | Status unknown | |||
| Dextrose | United States | Status unknown | |||
| Gallicum acidum | United States | Status unknown |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Often combined with
Substances it shares a medicine with.
Sources
Compiled by Prognia from the public medicine registers of FDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 1
- Medicines
- 9
- Companies
- 4
